Your browser doesn't support javascript.
loading
[Clinical and genetic features of children with 3-methylcrotonyl-coenzyme A carboxylase deficiency: an analysis of six cases]. / 3-甲基巴豆酰辅酶A羧化酶缺乏症6例患儿的临床特征及遗传学分析.
Zhang, Li-Ming; Wu, Sheng-Nan; Guo, Ya-Nan; Yang, Jian-Wei; Sun, Hong-Qi; Yang, Jun-Mei; Chen, Yong-Xing.
Afiliación
  • Zhang LM; Department of Endocrine Genetics and Metabolism, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China.
  • Yang JW; Department of Endocrine Genetics and Metabolism, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China.
  • Sun HQ; Department of Endocrine Genetics and Metabolism, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China.
  • Yang JM; Department of Endocrine Genetics and Metabolism, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018, China.
Zhongguo Dang Dai Er Ke Za Zhi ; 26(8): 845-851, 2024 Aug 15.
Article en Zh | MEDLINE | ID: mdl-39148390
ABSTRACT

OBJECTIVES:

To investigate the clinical and genetic features of children with 3-methylcrotonyl-coenzyme A carboxylase deficiency (MCCD).

METHODS:

A retrospective analysis was conducted on the clinical manifestations and genetic testing results of six children with MCCD who attended Children's Hospital Affiliated to Zhengzhou University from January 2018 to October 2023.

RESULTS:

Among the six children with MCCD, there were 4 boys and 2 girls, with a mean age of 7 days at the time of attending the hospital and 45 days at the time of confirmed diagnosis. Of all children, one had abnormal urine odor and five had no clinical symptoms. All six children had increases in blood 3-hydroxyisovaleryl carnitine and urinary 3-hydroxyisovaleric acid and 3-methylcrotonoylglycine, and five of them had a reduction in free carnitine. A total of six mutations were identified in the MCCC1 gene, i.e., c.1630del(p.R544Dfs*2), c.269A>G(p.D90G), c.1609T>A(p.F537I), c.639+2T>A, c.761+1G>T, and c.1331G>A(p.R444H), and three mutations were identified in the MCCC2 gene, i.e., c.838G>T(p.D280Y), c.592C>T(p.Q198*,366), and c.1342G>A(p.G448A). Among these mutations, c.269A>G(p.D90G) and c.1609T>A(p.F537I) had not been previously reported in the literature. There was one case of maternal MCCD, and the child carried a heterozygous mutation from her mother. Five children with a reduction in free carnitine were given supplementation of L-carnitine, and free carnitine was restored to the normal level at the last follow-up visit.

CONCLUSIONS:

This study identifies two new mutations, c.269A>G(p.D90G) and c.1609T>A(p.F537I), thereby expanding the mutation spectrum of the MCCC1 gene. A combination of blood amino acid and acylcarnitine profiles, urine organic acid analysis, and genetic testing can facilitate early diagnosis and treatment of MCCD, and provide essential data for genetic counseling.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carnitina / Mutación Límite: Female / Humans / Infant / Male / Newborn Idioma: Zh Revista: Zhongguo Dang Dai Er Ke Za Zhi Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carnitina / Mutación Límite: Female / Humans / Infant / Male / Newborn Idioma: Zh Revista: Zhongguo Dang Dai Er Ke Za Zhi Año: 2024 Tipo del documento: Article País de afiliación: China
...